Cash Flow | Sanofi India Ltd. | R Wadiwala Securities Pvt Ltd
NIFTY11050.25  +244.70 (+2.26%)
SENSEX37388.66  +835.06 (+2.28%)
  • top gainers
  • top losers
  • top volume
  • top value
investments Associate Login Online Trading Login
  • indian indices
  • global indices

We are investment service provider for Buy stocks , Low Stocks Brokerage , Stocks Portfolio Management in Surat , NRI Investment in Stocks , Share Broking Surat , Stock Broking Surat , Advisory Services Surat and Competetive Stocks Brokerage. investment advisory, financial integrity and prompt services in the whole of South Gujarat.

L
equity
Home Markets & NewsCompany ProfileCash Flow

SANOFI INDIA LTD.

NSE : SANOFIBSE : 500674ISIN CODE : INE058A01010Industry : Pharmaceuticals & DrugsHouse : Sanofi India - MNC
BSE8558.35177.1 (+2.11 %)
PREV CLOSE (Rs.) 8381.25
OPEN PRICE (Rs.) 8487.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 504
TODAY'S LOW / HIGH (Rs.)8302.15 8601.00
52 WK LOW / HIGH (Rs.)5684.95 8999
NSE8510.45123.45 (+1.47 %)
PREV CLOSE( Rs. ) 8387.00
OPEN PRICE (Rs.) 8400.00
BID PRICE (QTY) 8510.45 (10)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 16657
TODAY'S LOW / HIGH(Rs.) 8301.30 8631.65
52 WK LOW / HIGH (Rs.)5681.05 8989

Cash Flow

Select year
ParticularsDec2004Dec2003
Profit Before Tax2321.951487.69
Adjustment110.35148.79
Changes In working Capital-625.19-325.92
Cash Flow after changes in Working Capital1807.111310.57
Cash Flow from Operating Activities849.59817.65
Cash Flow from Investing Activities22.35-215.96
Cash Flow from Financing Activities-419.96-448.22
Net Cash Inflow / Outflow451.98153.47
Opening Cash & Cash Equivalents1348.271198.31
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANA
Effect of Foreign Exchange Fluctuations-1.36-3.51
Closing Cash & Cash Equivalent1798.881348.27
ATTENTION INVESTORS|KYC|IPO|PROPRIETARY TRADING
Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors.    
CORPORATE OFFICE
address
  • 9/2003-4,
  • Vishnu Priya Limda Chowk
  • Main Road
  • Surat – 395 003.
fax us @ +91-261-6673537
email us @ info@rwadiwala.com

Feed Back  | Terms & Conditions  | SEBI  | FMC  | NSE  | BSE  | MCX  | NCDEX  | IRDA  |  AMFI  | Disclaimer  | Privacy Policy  | Careers | User Agreements  | Ethics Policy  | Investor Protection  |  Dos and Don'ts   |  Rights and Obligations   |  Uniform Risk Disclosure   |   Important Policies   |  To File A Complaint on SCORES   | Sitemap 

SEBI Regn No. BSE - CM/F&O, NSE - CM/F&O/CDS: INZ000187332 | SEBI PMS regn no.: INP000004045 | MCX & NCDEX SEBI Regn No.: INZ000080636 | CDSL DP ID: 12043100
| R Wadiwala Securities Pvt Ltd - CIN: U67120GJ2004PTC044324 | R Wadiwala Commodities Pvt Ltd - CIN: U51109GJ2007PTC050176

Compliance Officer - Email ID: compliance@rwadiwala.com | Contact No.: 0261-6673542

The Stock Exchange, Mumbai is not in any manner answerable, responsible or liable to any person or persons for any acts of omission or commission, errors, mistakes and/or violation, actual or perceived, by us or our partners, agents, associates etc., of any of the Rules, Regulations, Bye-laws of the Stock Exchange, Mumbai, SEBI Act or any other laws in force from time to time. The Stock Exchange, Mumbai is not answerable, responsible or liable for any information on this Website or for any services rendered by us, our employees, and our servants.

Investor Greivance Redressal at support@rwadiwala.com

Copyright © 2016 | All Rights Reserved. R.Wadiwala group.

Designed & Developed by ●●● Accord Fintech Pvt. Ltd.